Page 107 - Oncology Coder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncology coder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncology Coder Today - Breaking & Trending Today

Indian American Doctor Is Republican Congressional Candidate From Kansas District 3

Dr Prasanth Reddy was born in Chennai, Tamil Nadu. ....

Tamil Nadu , United States , Prasanth Reddy , Sharice Davids , Jonathon Westbrook , Prasanth Reddy Drreddy , Karen Crnkovich , United States Air , Us Congress , Adventist Health System , Foundation Medicine , American Doctor , Indian American , Kansas District , United States Air Force , American Dream , Air Force , Adventist Health , Miss Out , Congressional Candidate , Kansas District 3 , Dr Prasanth Reddy , Indian Americans ,

Event to help Helena girl fight aggressive brain tumor

The event will be at Steed Industries, 3736 McHugh Drive, and will help the Schumacher family with travel and medical expenses. ....

Chloe Schumacher , Steed Industries , Hugh Drive , Bridget Korpi , He Economy ,

Texas Oncology's Sydney Townsend Spotlights Mental Health in Cancer Care Journey

Sydney Townsend, executive director of digital health at Texas Oncology, explains how cancer diagnosis and treatment can impact a patient’s mental well-being and how she assesses a patient’s overall cancer care experience. ....

United States , Sydney Townsend , Texas Oncology ,

Cancer Mortality Among US Hispanic Population Varies by Cancer Type, Age, Region

Between 1999 and 2020, rates of liver cancer deaths increased for Hispanic men and women, and pancreas and uterine cancer deaths have increased for Hispanic women. ....

United States , Hispanic White , Hispanic Black , African American , Hispanic Asian , Pacific Islander , Hispanic American Indian , Alaska Native , Among Hispanic , Jama Oncology , Wonder Database ,

Gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma

1. Combination therapy with gemcitabine and docetaxel for patients with metastatic or locally advanced synovial sarcoma met the primary endpoint of 3-month progression-free survival. Evidence Rating Level: 3 (Average) Synovial sarcoma (SS) accounts for 5-10% of all soft tissue sarcomas. SS carries a high risk for local recurrence and metastasis. The median 5-year overall survival ....

Minute Medicine Inc , Rating Level , Metastatic Cancer , Chronic Disease ,